PF-06445974
PF-06445974, a promising positron emission tomography (PET) lead, has exquisite potency at PDE4B with an IC50 50 values are 36, 4.7 and 17 nM for PDE4D, PDE4A and PDE4C, respectively. PF-06445974 has good selectivity over PDE4D, excellent brain permeability, and a high level of specific binding in the "cold tracer" study[1].
Product Specifications
CAS Number
2055776-17-3
Product Name Alternative
Mitoglitazone; CAY10415
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pf-06445974.html
Purity
98.59
Solubility
DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
N#CC1=CC=C(C=C1F)C2=C(C3=O)N(CCN3C4CC4)C5=CC=CN=C25
Molecular Formula
C20H15FN4O
Molecular Weight
346.36
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE4
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mucin 5AC (MUC5AC) (45M1), CF647 conjugate, 0.1mg/mL
HLA-DR (MHC II) (TAL 1B5), CF488A conjugate, 0.1mg/mL
Endothelin B Receptor (EDNRB) Human Gene Knockout Kit (CRISPR)
